Imricor Medical Systems, Inc. Stock
Equities
IMR
AU0000054942
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.880 AUD | +1.90% |
|
+18.99% | +22.88% |
| 12/01 | Imricor Medical Systems says FDA clears Vision-Mr diagnostic catheter | RE |
| 12/01 | Imricor Medical Systems Receives FDA Clearance; Shares Reach Four-Year High | MT |
| Capitalization | 403M 348M 324M 301M 561M 36.58B 603M 3.72B 1.47B 17.45B 1.51B 1.48B 63.71B | P/E ratio 2025 * |
-15.6x | P/E ratio 2026 * | -21.5x |
|---|---|---|---|---|---|
| Enterprise value | 382M 329M 306M 285M 531M 34.64B 571M 3.52B 1.39B 16.52B 1.43B 1.4B 60.33B | EV / Sales 2025 * |
345x | EV / Sales 2026 * | 76x |
| Free-Float |
62.1% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Imricor Medical Systems, Inc.
| 06/11 | Morgans rates IMR as Speculative Buy | AQ |
| 06/11 | First in Human Ischemic VT Ablation Successfully Performed in iCMR | BU |
| 11/07/25 | Morgans rates IMR as Speculative Buy | AQ |
| 11/06/25 | Morgans rates IMR as Speculative Buy | AQ |
| 23/04/25 | Imricor Commences VISABL-VT Trial | BU |
More news
| 1 day | +1.90% | ||
| 1 week | +18.99% | ||
| Current month | +22.88% | ||
| 1 month | +28.77% | ||
| 3 months | +25.33% | ||
| 6 months | +45.17% | ||
| Current year | +22.88% |
| 1 week | 1.7 | 1.99 | |
| 1 month | 1.42 | 1.99 | |
| Current year | 1.47 | 1.99 | |
| 1 year | 1.12 | 1.99 | |
| 3 years | 0.18 | 1.99 | |
| 5 years | 0.1 | 2.5 | |
| 10 years | 0.1 | 2.94 |
| Manager | Title | Age | Since |
|---|---|---|---|
Steven Wedan
CEO | Chief Executive Officer | 58 | 01/01/2006 |
Jonathon Gut
DFI | Director of Finance/CFO | - | 01/05/2021 |
Kate Lindborg
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Steven Wedan
CHM | Chairman | 58 | 01/01/2006 |
Mark Tibbles
BRD | Director/Board Member | 59 | 01/09/2014 |
Peter McGregor
BRD | Director/Board Member | 60 | 01/05/2019 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.90% | +18.99% | +35.25% | +478.46% | 403M | ||
| -0.95% | -0.02% | +10.55% | +5.25% | 232B | ||
| -1.17% | -8.74% | -9.73% | +104.41% | 190B | ||
| -1.63% | -1.00% | -0.99% | -14.16% | 167B | ||
| -2.18% | -9.80% | -10.73% | +91.29% | 131B | ||
| -1.07% | -0.45% | -11.20% | -7.07% | 59.92B | ||
| -0.17% | -0.92% | +20.88% | +6.96% | 48.95B | ||
| -3.58% | -5.98% | -5.24% | -10.14% | 39.59B | ||
| -1.20% | +2.02% | +7.42% | +14.29% | 37.52B | ||
| -0.92% | -6.34% | -3.53% | +29.09% | 37.24B | ||
| Average | -1.10% | -1.22% | +3.27% | +69.84% | 94.3B | |
| Weighted average by Cap. | -1.37% | -3.79% | -0.69% | +33.84% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.1M 953K 887K 826K 1.54M 100M 1.65M 10.2M 4.02M 47.82M 4.14M 4.06M 175M | 5.21M 4.49M 4.18M 3.9M 7.25M 473M 7.8M 48.13M 18.98M 226M 19.55M 19.15M 824M |
| Net income | -24.1M -20.78M -19.34M -18.01M -33.53M -2.19B -36.07M -222M -87.73M -1.04B -90.38M -88.52M -3.81B | -17.75M -15.3M -14.25M -13.26M -24.69M -1.61B -26.57M -164M -64.61M -768M -66.56M -65.19M -2.81B |
| Net Debt | -21.42M -18.46M -17.19M -16M -29.79M -1.94B -32.05M -198M -77.95M -927M -80.31M -78.66M -3.38B | -6.96M -6M -5.59M -5.2M -9.69M -632M -10.42M -64.29M -25.35M -301M -26.12M -25.58M -1.1B |
More financial data
* Estimated data
Employees
-
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/01/26 | 1.880 $ | +1.90% | 164,134 |
| 15/01/26 | 1.845 $ | -0.27% | 75,685 |
| 14/01/26 | 1.850 $ | +1.65% | 162,015 |
| 13/01/26 | 1.820 $ | -1.62% | 205,620 |
| 12/01/26 | 1.850 $ | +17.09% | 1,248,539 |
Delayed Quote Australian S.E., 16 January 2026 at 04:10 pm AEDT
More quotesSell
Buy

Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.256USD
Average target price
1.415USD
Spread / Average Target
+12.65%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- IMR Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















